Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
Evan Seigerman, an analyst from BMO Capital, maintained the Buy rating on Pfizer (PFE – Research Report). The associated price target ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Pfizer Inc PFE rose during ...
Consequently, Bansal believes that Pfizer’s stock should be held as it is not expected to outperform or underperform significantly in the near future. Bansal covers the Healthcare sector, focusing ...
Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...
The company also recently reported positive phase 2 results for ponsegromab, a potential medicine for cancer cachexia -- ...
We recently compiled a list of the 8 Best Wide Moat Stocks to Buy According to Analysts. In this article, we are going to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback